Page last updated: 2024-08-24

telmisartan and 9,10-epoxy-12-octadecenoate

telmisartan has been researched along with 9,10-epoxy-12-octadecenoate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angioni, C; de Bruin, N; Geisslinger, G; Hofmann, M; Hohman, SW; Ji, RR; Jordan, H; Kuzikov, M; Liu, D; Lu, R; Meyer Dos Santos, S; Park, CK; Parnham, MJ; Schäfer, SM; Schmidt, M; Scholich, K; Schreiber, Y; Sisignano, M; Suo, J; Woolf, CJ; Yekkirala, AS; Zhang, DD; Zimmer, B; Zinn, S1

Other Studies

1 other study(ies) available for telmisartan and 9,10-epoxy-12-octadecenoate

ArticleYear
Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, 11-01, Volume: 113, Issue:44

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Agents, Phytogenic; Benzimidazoles; Benzoates; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Female; Ganglia, Spinal; Gene Expression Regulation, Enzymologic; HEK293 Cells; Humans; Linoleic Acids; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Neuralgia; Paclitaxel; Pain Threshold; Telmisartan

2016
chemdatabank.com